AXA profit drops 18% in 2020 but 'resilient' in face of pandemic
French insurer AXA saw its profits slip a little in 2020 due to the impact of COVID-19 claims and lower new business activity but its chief executive Thomas Buberl said the group was "resilient" due to its strategic choices and business mix.
AXA posted a net profit of €3.16 billion in 2020, a decline of 18 percent from €3.86 billion in 2019.
Its total revenues for the year were down just 1 percent to €97 billion, reflecting strong growth in the first and the fourth quarter of 2020.
The insurer posted 1 percent growth in its property and casualty segment, 6 percent in health, and 4 percent growth in its asset management segment.
Meanwhile, AXA saw lower revenues in personal lines (-1 percent) primarily due to lower new business activity during the lockdown periods across most geographies.
Revenues in its life & savings also declined by 6 percent mostly from lower sales in France and in Europe, largely impacted by COVID-19.
The overall impact on 2020 underlying earnings for the group from pandemic-related P&C claims and solidarity measures was €1.5 billion, post-tax and net of reinsurance.
In property and casualty lines the all year combined ratio was up 3.2 points to 99.5 percent, largely reflecting the impact from COVID-19 claims (+3.1 points) and higher natural catastrophe charges (+0.2 point) at AXA XL.
In its health business, the combined ratio increased by 0.5 point to 94.5 percent.
Thomas Buberl, chief executive officer of AXA, said: “AXA’s revenues were resilient in 2020, down just 1 percent compared to the previous year, reflecting the relevance of our strategic choices and business mix. Our preferred segments, P&C Commercial lines, Health and Protection, continued to perform well, growing by 3 percent in 2020 and accelerating in the fourth quarter (+5 percent).”
“We are confident in our earnings outlook and have set a 2020 starting base of Euro 6.3 billion underlying earnings for our 2021 - 2023 strategic plan targets,” he added.
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze